Search Results for keywords:"Democratic Republic of the Congo"

Found 2 results
Skip to main content

Search Results: keywords:"Democratic Republic of the Congo"

  • Type:Notice
    Citation:90 FR 10847
    Reading Time:about 3 minutes

    The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) has announced that several individuals and entities have been added to its Specially Designated Nationals and Blocked Persons List. This means their property and interests that are within U.S. jurisdiction are now blocked, and U.S. individuals and companies are generally not allowed to do business with them. The designations include James Kabarebe from Rwanda and Lawrence Kanyuka Kingston linked to the Democratic Republic of the Congo, along with his business activities related to Kingston Fresh Ltd and Kingston Holding. These actions are based on sanctions aimed at addressing the conflict in the Democratic Republic of the Congo.

    Simple Explanation

    The U.S. Treasury has a special list of people and businesses that people in the U.S. aren't allowed to do business with. They added some new names to this list because they are connected to problems happening in the Democratic Republic of the Congo.

  • Type:Notice
    Citation:89 FR 99267
    Reading Time:about 4 minutes

    The National Institute of Allergy and Infectious Diseases (NIAID) is offering royalty-free access to a specially developed starting material, known as "MVA clone-1," for creating and commercializing a vaccine against mpox. This initiative aims to improve vaccine access, especially in underserved regions, and respond to a 2024 public health emergency called by the World Health Organization due to a significant outbreak in the Democratic Republic of the Congo. Interested parties with solid plans to develop and distribute the vaccine in high-need areas can collaborate with NIAID. The material shows promise as it is similar to an already approved vaccine and has been shown to protect against mpox in both normal and at-risk populations.

    Simple Explanation

    The U.S. Government wants to share a special material called "MVA clone-1" to help companies make a vaccine for mpox, especially in places where people really need it, without asking for any money in return. However, the rules on who gets it and how they will make sure everyone gets the vaccine are not very clear.